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Abstract NF-Y, also referred to as CCAAT-binding factor, is
a major CCAAT-binding transcription factor. The present study
demonstrated that the 3P-£anking region of the CCAAT box is
involved in the formation of a stable NF-YWDNA complex. An
electrophoretic mobility shift assay showed that the interaction
of NF-Y with DNA 15 bp downstream of the CCAAT box
alters not only the a⁄nity of NF-Y for its binding site but
also the electrophoretic mobility of the NF-YWDNA complex.
This interaction is accompanied by a conformational change
of NF-Y as demonstrated by a change in the reactivity of an
anti-NF-YA antibody to the NF-YWDNA complex.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Gene expression is regulated by an assortment of transcrip-
tion factors unique to speci¢c cellular contexts. Since the orig-
inal domain-swapping experiments [1], it has generally been
thought that transcription factors are composed of separate,
autonomous modules of DNA-binding domains (DBD),
which recruit the protein to relevant promoter and transcrip-
tion activation domains [2]. Recently, studies on intracellular
receptor families and other classes of transcription factors
have modi¢ed this view by proposing a transcription model
in which DBD play a more active role [3]. That is, DNA is not
only a mere binding site for transcription factors, but also an
allosteric ligand whose binding can regulate the function of
transcription factors. The allosteric e¡ect is accompanied by a
DNA-induced conformational change in the protein, and this
structural change modi¢es its inherent properties including
transcriptional activating potential as well as a⁄nity for other
components of the transcriptional apparatus. The DNA se-
quence itself can contain information that dictates a speci¢c
conformational change in the protein, resulting in a di¡erent
transcriptional outcome [4^6].
Among several CCAAT-binding proteins isolated so far,
the heterotrimeric transcription factor NF-Y (also referred
to as CCAAT-binding factor, CBF) has been shown to be
an essential transcription factor responsible for the regulation
of most CCAAT box-containing promoters [7^9]. NF-Y or-
ganizes the transcriptional machinery by bending the DNA
chain and interacting with other regulatory proteins including
TBP, TAFs, Sp1, RFX and P/CAF [9]. All three subunits of
NF-Y, namely, NF-YA, -YB and -YC, appear to participate
in forming the surfaces required for DNA binding [9^11].
While NF-Y binding to the CCAAT box exhibits a strict
requirement for the pentanucleotide [12], previous studies
such as random binding-site selection experiments [13] and
compilation of bona ¢de NF-Y binding sites [7] have sug-
gested that, in addition to the pentanucleotide, short segments
of adjacent £anking sequences are important for NF-Y bind-
ing. Moreover, contacts between NF-Y and the more distal
£anking sequences were observed in hydroxyl radical foot-
printing [13]. However, it remains to be clari¢ed to what ex-
tent these distal £anking regions of DNA are involved in
NF-Y binding.
In this study, we demonstrate that the distal contact with
the 3P-£anking DNA is important for NF-Y binding to DNA.
Furthermore, we present evidence for a conformational
change in NF-Y that is induced by the interaction between
NF-Y and the 3P-£anking DNA.
2. Materials and methods
2.1. Electrophoretic mobility shift assay (EMSA)
Nuclear extract was prepared from Chinese hamster ovary (CHO)
and di¡erentiated mouse P19 embryonic carcinoma cells by the meth-
od of Dignam et al. [14]. Unless speci¢ed otherwise, EMSA and anti-
body supershift assay were performed as described previously [15].
The GC box sequence in the extracellular signal-regulated kinase 2
(ERK2) 28R, 31R and 33R probes used in the EMSA shown in Figs.
2^5 was altered to GttCGG to exclude Sp1/Sp3 binding [15]. Poly-
clonal rabbit antibodies against the NF-YA C-terminal peptide (anti-
NF-YAC7) and against NF-YB [16] were kindly provided by Dr. R.
Mantovani (University of Modena, Italy). Polyclonal rabbit antibody
against the NF-YA N-terminal peptide (hereafter referred to as anti-
NF-YAN) was purchased from Rockland (Gilbertsville, PA, USA).
Polyclonal rabbit anti-CBF-C (NF-YC) antibody [17] was kindly pro-
vided by Dr. T. Taira (Hokkaido University, Sapporo, Japan).
2.2. Production of recombinant proteins
cDNAs of mouse NF-YA, -YB and -YC were ampli¢ed by PCR
from 3T3-L1 cell cDNA and cloned into pGEX-6P-2 (Amersham
Biosciences). To produce NF-YA protein, the pGEX-YA construct
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was introduced into BL21-Codon-Plus (DE3) RIL cells (Stratagene).
The cells expressing the protein were lysed with bu¡er A (25 mM
Tris^HCl (pH 7.5), 1% n-octylthioglucopyranoside, 1 mM dithiothrei-
tol (DTT), 1 mM phenylmethylsulfonyl £uoride, 2 Wg/ml aprotinin,
2.5 Wg/ml leupeptin and 2.5 Wg/ml pepstatin). The inclusion bodies
were collected, washed twice in 10-fold diluted bu¡er A, and solubi-
lized in 8 M urea, 50 mM Tris^HCl (pH 7.0), 1 mM EDTA and 1 mM
DTT. The proteins were refolded by stepwise dialysis against decreas-
ing concentrations of urea (7, 6, 5, 4, 3, 2, 1 and 0.5 M), and then
dialyzed against 50 mM Tris^HCl (pH 7.0 at 25‡C), 0.15 M NaCl,
1 mM EDTA and 1 mM DTT. GST-YA was puri¢ed over gluta-
thione Sepharose 4B (Amersham Biosciences), and YA protein was
eluted by on-column cleavage with PreScission protease (Amersham
Biosciences). The YB subunit was also prepared as described above
for YA. The GST-YC protein was puri¢ed as a complex with the YB
subunit. Three milligrams of the inclusion body fraction of GST-YC-
expressing bacteria and 1.5 mg of the puri¢ed YB protein were com-
bined in 8 M urea solution and refolded together by stepwise dialysis.
After puri¢cation of the YB/GSTWYC complex over glutathione Seph-
arose, the YB/YC moiety was eluted by on-column cleavage and fur-
ther puri¢ed using a MonoQ HR 5/5 column (Amersham Bioscien-
ces).
3. Results
Our previous report characterizing NF-Y interaction with
the mouse ERK2 promoter raised questions about the role of
£anking sequences in NF-YWCCAAT box binding [15]. As
shown in Fig. 1 (lanes 3 and 4), NF-Y e⁄ciently bound to
the ERK2 33R probe (the number preceding ‘R’ in the probe
nomenclature denotes the length of the 3P-£anking DNA;
Table 1). In contrast, it failed to bind to either the ERK2
393/351 probe with a 29-bp 5P extension (lane 5) or the 9R
probe containing the CCAAT core-binding sequence (lane 2).
A possible explanation for these observations is that the 9-bp
3P-£anking DNA in both 9R and 393/351 probes is inad-
equate for e⁄cient NF-Y binding. We tested this possibility
by a competitive EMSA using oligonucleotides consisting of
8 bp 5P-£anking DNA, the core pentanucleotide, and 3P-£ank-
ing DNA of increasing lengths. The NF-Y binding to radio-
labeled 33R probe was challenged with a 100-fold excess of
each unlabeled oligonucleotide (Fig. 2). As expected, 9R oli-
gonucleotide failed to compete for NF-Y binding (lane 2).
11R and 13R oligonucleotides showed an increasing ability
to compete (lanes 3 and 4). The addition of oligonucleotides
having more than 15 bp of 3P-£anking DNA abolished the
NF-Y binding to labeled 33R probe (lanes 5^8). This ¢nding
suggests that the e⁄cient binding of NF-Y to the ERK2
CCAAT box requires an interaction with the 3P-£anking
DNA in addition to the core pentanucleotide.
We next investigated an unexpected di¡erence in the elec-
trophoretic mobility between the NF-YWDNA complexes ob-
tained with the 33R probe (Fig. 1, lane 3, open arrowhead)
and 24-bp EK Y box probe, a classical NF-Y binding site
(Fig. 1, lane 1, closed arrowhead). We compared the mobility
of the NF-YWDNA complexes formed with 17R and 28R
probes derived from three di¡erent promoter sequences
(ERK2, EK and K2(I)col ; Table 1) in order to examine
whether the length of the 3P-£anking DNA simply a¡ects
the mobility of the NF-YWDNA complex formed with each
DNA. As shown in Fig. 3, all the NF-YWDNA complexes
obtained with the three di¡erent 17R probes exhibited almost
identical mobility. On the other hand, the complexes obtained
with the 28R probes all migrated faster than the complexes
with the 17R probes did. This result was demonstrated with
puri¢ed recombinant NF-Y subunits as well as the nuclear
extracts, indicating that the result was attributed to an inher-
ent property of NF-Y, but not to its interaction with other
nuclear proteins. Thus, in all three promoters examined the
length of the 3P-£anking DNA a¡ected the electrophoretic
mobility of the NF-YWDNA complex, irrespective of the se-
quences surrounding the CCAT box.
The change in electrophoretic mobility of the NF-YWDNA
complex was further analyzed using ERK2 probes with the
Fig. 1. E⁄cient binding of NF-Y to the CCAAT box requires a
speci¢c length of 3P-£anking sequence. EMSA was performed with
P19 cell nuclear extract. Probes used are EK Y box (lane 1), ERK2
9R (lane 2), ERK2 33R GC box mutant (lane 3), wild-type 33R
(lane 4) and ERK2 393/351 (lane 5). The major bands of lower
mobility in lanes 4 and 5 are derived from Sp1/Sp3 binding [15].
Fig. 2. Critical length of the 3P-£anking DNA for NF-Y binding to
the CCAAT box probe. Competitive EMSA was performed with
P19 cell nuclear extract and ERK2 33R GC box mutant probe in
the absence (lane 1) or presence (lanes 2^8) of a 100-fold excess of
unlabeled oligonucleotides with 3P-£anking DNA of increasing
length.
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3P-£anking DNA of increasing length (Fig. 4). As expected
from the results of the competitive EMSA, the a⁄nity of
NF-Y for a probe was gradually elevated as the length of
the 3P-£anking DNA increased up to 22 bp (lanes 1^6). The
NF-YWDNA complexes formed with 9R, 11R and 13R probes
showed the same mobility (lanes 1^3), suggesting that the mo-
bility of the complex appeared to be insensitive to the changes
in mass and charge provided by the increased length of DNA.
However, the complexes formed with 17R to 28R probes
showed a gradual increase in the mobility (lanes 4^8). This
alteration of electrophoretic mobility, which is conferred by
the interaction with the 3P-£anking DNA, suggests a confor-
mational change in the protein, a phenomenon similar to that
observed with thyroid hormone receptor, which exhibits a
similar alteration of electrophoretic mobility of proteinWDNA
complex due to a DNA-induced conformational change in the
protein moiety [18,19].
DNA binding to transcription factors can induce conforma-
tional changes which alter the immunoreactivity to their spe-
ci¢c antibodies. This is the basis of antibody supershift assays
used to detect such DNA-induced conformational changes
[20^22]. We examined the conformational changes in NF-
YWDNA complexes formed with either 17R or 33R probe us-
ing antibodies against each of the three NF-Y subunits (Fig.
5). NF-Y bound to the probes was reactive to anti-NF-YAN,
anti-NF-YB and anti-NF-YC antibodies as demonstrated by
the retardation of the NF-YWDNA complexes; for unknown
reasons, anti-NF-YAC7 antibody was ine¡ective in the range
of concentrations tested. These results con¢rmed that the
NF-Y bound to 17R and 33R probes contains all three sub-
units and, therefore, excluded the possibility that the higher
mobility of the NF-YW33R complex resulted from the dissoci-
ation of any of the subunits.
NF-YWDNA complexes formed with17R and 33R probes
showed distinct reactivities to anti-NF-YAN antibody. In con-
trast to a single supershifted species derived from the NF-
YW17R complex (lane 4, asterisk), reaction of anti-NF-YAN
antibody with the NF-YW33R complex gave rise to two super-
shifted species (lane 10, open and closed circles). One mi-
grated faster than the supershifted NF-YW17R complex, and
the other migrated more slowly. Of these two species, the
more slowly migrating one was the main supershifted species
at a low concentration of anti-NF-YAN (lane 9, open circle).
As the concentration of the antibody increased, the faster-
migrating species became predominant (lanes 10 and 11,
closed circle), indicating that the more slowly migrating spe-
cies represents an intermediate conformation of the antibo-
dyWNF-YWDNA complex that eventually gives rise to the faster
one by reacting with a higher concentration of the antibody.
Similar results with anti-NF-YAN antibody were also ob-
served using EK and K2(I) collagen probes (data not shown),
indicating that the observation was not unique to the ERK2
sequence. Taken together, these observations with the anti-
NF-YAN antibody corroborated the structural change in
NF-Y induced by the 3P-£anking DNA.
4. Discussion
Contacts between NF-Y and the 3P-£anking DNA have
been shown by hydroxyl radical footprinting [13]. In addition
to the CCAAT box, distal £anking regions located on each
side of the core sequence were protected from hydroxyl rad-
ical cleavage. The reported distal boundary of the 3P protected
region, which is 14^16 bp away from the pentanucleotide,
agrees well with the boundary of the 3P-£anking DNA deter-
mined in this study as the minimal length required for e⁄cient
NF-Y binding. Similar distal contacts as well as central se-
Table 1
Oligonucleotide probes used in this study
EK Y box 5P-CAACTTTTAACCAATCAGAAAAAT-3P
ERK2 9R 5P-AAGAGAAGCCAATCAACACGCA-3P
ERK2 17R 5P-AAGAGAAGCCAATCAACACGCACGCCCTTG-3P
EK 17R 5P ACTTTTAACCAATCAGAAAAATGTTTCAGA 3P
K2(I)col 17R 5P-CGTCTCCACCAATGGGAGGGCTAGGGCTAG-3P
ERK2 28R 5P-AAGAGAAGCCAATCAACACGCACGCCCTTGACTCCGCCCTA-3P
EK 28R 5P-ACTTTTAACCAATCAGAAAAATGTTTCAGACTGACACATCT-3P
K2(I)col 28R 5P-CGTCTCCACCAATGGGAGGGCTAGGGCTAGGGGCCCGGGAC-3P
ERK2 33R 5P-AAGAGAAGCCAATCAACACGCACGCCCTTGACTCCGCCCTAGCGCC-3P
ERK2 393/351 5P-CGAGACTCCGCCCTCTCTACCAAGAGAAGCCAATCAACACGCA-3P
The sequences were taken from: EK, mouse MHC class II EK gene (GenBank accession number M17389); ERK2, mouse ERK2 gene
(D87264); K2(I)col, mouse K2(I) collagen gene (M13124). The CCAAT box and GC box are underlined.
Fig. 3. Electrophoretic mobility of the NF-YWDNA complex corre-
lates with the length of the 3P-£anking DNA, but not with the dif-
ferences in the sequences surrounding the CCAAT box. The results
with P19 cell nuclear extracts (left half panel) and with recombinant
NF-Y subunits are shown (right half). As Kcol probes have a higher
a⁄nity for NF-Y, half as much of the protein was used for the
Kcol probes than for the ERK2 and EK probes. We also observed
similar results with CHO cell nuclear extracts (data not shown).
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quence-speci¢c ones have also been used in several DNA-
binding proteins to form a stable DNAWprotein complex
[23^25]. Recently, a crystal structure of the NF-YB/NF-YC
heterodimer has been reported [26]. The structure of the NF-
YB/NF-YC dimer is highly similar to that of the histone
dimer H2A/H2B [27], as well as NC2K/2L [28], a heterodimer-
ic complex that modulates TATA-dependent transcription. A
comparison of the structure of NF-YB/NF-YC to that of the
H2A/H2BWDNA complex in the nucleosome core particle sug-
gests that the NF-YB/NF-YC dimer may also interact with
DNA at two di¡erent sites, K1K1 and L1L2 [26]. The inter-
actions made by the two loops that comprise the L1L2 site,
located at the extremity of the dimer, are thought to occur in
the distal CCAAT box-£anking region identi¢ed in this re-
port. It has also been reported that the L1L2 site makes con-
tacts with the DNA backbone, which could explain the lack of
an apparent sequence preference in this region of NF-Y bind-
ing sites.
It was previously indicated that a stable NF-YB/NF-YC
heterodimer initially forms an unstable complex with NF-
YA by weak interaction, and then binding of DNA to the
trimeric complex stabilizes the interaction between NF-YA
and the heterodimer, resulting in a stable NF-YWDNA com-
plex [10]. For this stabilization, a conformational change in
NF-Y is likely to be important since the increase in the
amount of the NF-YWDNA complex formed correlated with
that in the electrophoretic mobility when the length of the
3P DNA sequence of the probe increased (Fig. 4, lanes 1^7).
Thermodynamic studies have shown that DNA binding
drives the structural changes in DNA-binding proteins [29].
In a nuclear magnetic resonance study of a HoxB1WPbx1WDNA
complex, it was also demonstrated that a DNA-induced con-
formational change in Pbx1 promotes the formation of a ter-
nary complex by facilitating HoxB1 binding to a reorganized
K-helix of Pbx1 [30]. Such examples suggest that a conforma-
tional change in NF-Y could a¡ect the transcriptional appa-
ratus by altering the interaction between NF-Y and other
regulatory components. For example, a structural change in
NF-Y might account for the cooperative binding of NF-Y
and RFX to the X-Y promoter elements even though NF-Y
and RFX do not interact in solution in the absence of DNA
[31]. The ¢ndings obtained in this report will facilitate future
studies investigating the coordinate e¡ects of the DNA-bind-
ing, structural change, and concomitant functional modula-
tion of NF-Y.
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